Ghost Tree Capital’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Ghost Tree Capital’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-75,000	Closed	-$4.64M	–	53
2022 Q3	$4.64M	Sell	75,000 -25,000	-25%	-$1.75M	1.3%	28
2022 Q2	$7.98M	Buy	+100,000	New	+$9.47M	4.15%	8
2018 Q1	–	Sell	-400,000	Closed	-$5.84M	–	75
2017 Q4	$5.84M	Buy	+400,000	New	+$5.62M	1.37%	29
2016 Q4	–	Sell	-225,000	Closed	-$4.08M	–	105
2016 Q3	$4.08M	Sell	225,000 -25,000	-10%	-$488K	0.66%	50
2016 Q2	$4.12M	Sell	250,000 -175,000	-41%	-$2.83M	1.19%	35
2016 Q1	$7.04M	Buy	+425,000	New	+$7.44M	3.98%	7
2015 Q4	–	Sell	-275,000	Closed	-$5.45M	–	82
2015 Q3	$5.45M	Buy	275,000 +75,000	+38%	+$2.37M	2.45%	14
2015 Q2	$6.95M	Buy	+200,000	New	+$6.1M	2.25%	13
2015 Q1	–	Sell	-300,000	Closed	-$3.87M	–	88
2014 Q4	$3.87M	Sell	300,000 -125,000	-29%	-$1.56M	1.86%	22
2014 Q3	$5.22M	Buy	+425,000	New	+$4.94M	2.83%	6
2014 Q2	–	Sell	-130,000	Closed	-$1.97M	–	83
2014 Q1	$1.97M	Buy	130,000 +30,000	+30%	+$339K	1.17%	31
2013 Q4	$762K	Buy	+100,000	New	+$539K	0.47%	55

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Ghost Tree Capital's HZNP Position: Q4 2022 in Review

Ghost Tree Capital sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2022, closing a stake of 75,000 shares — an estimated $4.64M sold.

Ghost Tree Capital first reported a position in HZNP in Q4 2013 and held it in 12 quarters. The position peaked at $7.98M in Q2 2022. 613 funds tracked by Wall St. Rank hold HZNP as of Q4 2022.

Ghost Tree Capital reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2022 after selling out during the quarter.
Ghost Tree Capital sold 75,000 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2022, an estimated $4.64M.
Ghost Tree Capital first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2013 and held it in 12 quarters.
Ghost Tree Capital's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $7.98M in Q2 2022.
613 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2022.

Based on Ghost Tree Capital's 13F filing for Q4 2022, filed 14 Feb 2023.